The grant date fair value of restricted share units and performance share units is based on the market value of the Company's ordinary shares on the date of grant.


	Three Months Ended				Six Months Ended
(in thousands)	December 30, 2022		December 24, 2021		December 30, 2022		December 24, 2021
Share-based compensation expense by type of award:
Restricted share units	$	3,999	$	3,671	$	8,900	$	8,595
Performance share units	2,776		3,015		5,598		7,383
Total share-based compensation expense	6,775		6,686		14,498		15,978
Tax effect on share-based compensation expense	—		—		—		—
Net effect on share-based compensation expense	$	6,775	$	6,686	$	14,498	$	15,978


	Three Months Ended				Six Months Ended
(in thousands)	December 30, 2022		December 24, 2021		December 30, 2022		December 24, 2021
Cost of revenue	$	1,660	$	1,421	$	3,576	$	3,396
Selling, general and administrative expense	5,115		5,265		10,922		12,582
Total share-based compensation expense	$	6,775	$	6,686	$	14,498	$	15,978

The Company did not capitalize any share-based compensation expense as part of any asset costs during the three and six months ended December 30, 2022 and December 24, 2021.

On December 12, 2019, the Company’s shareholders approved Fabrinet’s 2020 Equity Incentive Plan (the “2020 Plan”). Upon the approval of the 2020 Plan, Fabrinet’s Amended and Restated 2010 Performance Incentive Plan (the “2010 Plan”) was simultaneously terminated. The 2020 Plan provides for the grant of equity awards thereunder with respect to (i) 1,700,000 ordinary shares, plus (ii) up to 1,300,000 ordinary shares that, as of immediately prior to the termination of the 2010 Plan, had been reserved but not issued pursuant to any awards granted under the 2010 Plan and are not subject to any awards thereunder. Upon termination of the 2010 Plan, 1,281,619 ordinary shares were reserved for issuance under the 2020 Plan pursuant to clause (ii) of the preceding sentence.

As of December 30, 2022, there were 362,057 restricted share units outstanding, 204,016 performance share units outstanding and 1,963,486 ordinary shares available for future grant under the 2020 Plan.

As of December 30, 2022, there were 41,996 restricted share units outstanding under the 2010 Plan. No ordinary shares are available for future grant under the 2010 Plan.

On November 2, 2017, the Company adopted the 2017 Inducement Equity Incentive Plan (the “2017 Inducement Plan”) with a reserve of 160,000 ordinary shares authorized for future issuance solely for the granting of inducement share options and equity awards to new employees. The 2017 Inducement Plan was adopted without shareholder approval in reliance on the “employment inducement exemption” provided under the New York Stock Exchange Listed Company Manual. As of December 30, 2022, there were no awards outstanding and 111,347 ordinary shares available for future grant under the 2017 Inducement Plan.

Restricted share units granted to employees generally vest in equal installments over three or four years on each anniversary of the vesting commencement date. Restricted share units granted to non-employee directors generally cliff vest 100% on the first of January, approximately one year from the grant date, provided the director continues to serve through such date.

Performance share units granted to executives will vest, if at all, at the end of a two-year performance period based on the Company’s achievement of pre-defined performance criteria, which consist of revenue and non-GAAP operating margin targets. The actual number of performance share units that may vest at the end of the performance period ranges from 0% to 100% of the award grant.


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
Balance as of June 24, 2022	459,626	$	75.14
Granted	148,830	$	119.14
Vested	(189,375)	$	64.23
Forfeited	(15,028)	$	89.86
Balance as of December 30, 2022	404,053	$	95.91


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
Balance as of June 25, 2021	641,875	$	55.74
Granted	154,893	$	102.70
Vested	(271,396)	$	50.74
Forfeited	(18,101)	$	68.49
Balance as of December 24, 2021	507,271	$	72.29


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
Balance as of June 24, 2022	285,882	$	81.64
Granted	97,142	$	117.35
Vested	(179,008)	$	70.05
Forfeited	—	$	—
Balance as of December 30, 2022	204,016	$	108.81


	Number of Shares	Weighted- Average Grant Date Fair Value Per Share
Balance as of June 25, 2021	427,028	$	57.82
Granted	110,832	$	101.05
Vested	(190,213)	48.65
Forfeited	(52,097)	$	48.65
Balance as of December 24, 2021	295,550	$	81.55

As of December 30, 2022, there was $18.7 million and $12.2 million of unrecognized share-based compensation expense related to restricted share units and performance share units, respectively, under the Equity Incentive Plans that is expected to be recorded over a weighted-average period of 2.7 and 1.3 years, respectively.

For the six months ended December 30, 2022 and December 24, 2021, the Company withheld an aggregate of 165,502 shares and 201,658 shares, respectively, upon the vesting of restricted share units and performance shares units, based upon the closing share price on the vesting date to settle employee tax withholding obligations. For the six months ended December 30, 2022 and December 24, 2021, the Company then remitted cash of $16.8 million and $19.5 million, respectively, to the appropriate taxing authorities and presented it as a financing activity within the unaudited condensed consolidated statements of cash flows. The payment was recorded as a reduction of additional paid-in capital.